Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acarix, Agendia, Dermtech, Todos Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Afimmune, Aztherapies, Bexion, Biolinerx, Biontech, Bioversys, Boehringer, Chiasma, Cogent, Enlivex, Genoscience, Gilead, Greenwich, Helixmith, Hepion, Kazia, Lilly, Milestone, Moderna, Neurosense, Oncosec, Organicell, Pfizer, Pionyr, Puretech, Sanofi, Sernova, VBI.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Rhythm AI, Sino Medical, Smith+Nephew, Spineology.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Asieris, Astrazeneca, Bioaegis, Biological E., Corvus, Curevac, Cynata, Dynavax, Glaxosmithkline, Immunitybio, Medicago, Merck, Mesoblast, Moderna, Neurorx, Organicell, PTC, RDIF, Redhill, Relief, Revelation, Reven, Sagent, Selva, Shanghai Henlius, Takeda, UVA.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aivita, Ampio, Avrobio, Bayer, Beigene, Brainstorm, Cerebral, Cymabay, Dicerna, Eicosis, Eiger, Galderma, Jupiter, Kangpu, Kiniksa, Lexicon, Mydecine, Novo, Palladio, Poxel, PTC, Rigel, Trippbio, Urogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cala Health, Istar Medical, Liberate Medical, Qlarity Imaging.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Akebia, Alligator, Aptevo, Atara, Beyondspring, Bioaegis, Biological E., Calypso, Cerevance, Dynavax, Genenta, Intravacc, Karyopharm, Kodiak, Moderna, Medexus, Obseva, Precigen, PTC, Rapt, Redhill, Revelation, Rhovac.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptive Biotechnologies, Glympse Bio, Helio Health, Inari Medical, Pq Bypass.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89 Bio, Akero, Albireo, Alnylam, Amarin Annexon, Arrowhead, Biocryst, Bridgebio, Durect, Esperion, Gemini, Greenwich, Horizon, Incarda, Ionis, Mirum, Myokardia, Navidea, Neurorx, NGM, Nkarta, Novartis, Surface, Takeda, VBI.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angiodynamics, Castle Biosciences, Integrity Implants.